A PILOT STUDY ON THE NON-INVASIVE MANAGEMENT OF TRACHEOBRONCHIAL SECRETIONS IN TRACHEOSTOMISED PATIENTS
The aim of our study was to assess the safety, efficacy and feasibility of an Expiratory Flow Accelerator (EFA) device, Free Aspire, in reducing the need for daily suctions in tracheostomised (TCS) patients
Methods: Twenty‐five patients were investigated.
The number of superficial/deep suctions, shallows, arterial blood gas (ABG) analysis, perception of mucus encumbrance (Visual Numeric Scale, VNS) and adverse event were recorded for five days.
On the first two days, suctioning was performed as usual, on the following three days, patients were treated also with EFA®.
Conclusion: EFA® may be useful for managing secretions in TCS patients, as it can reduce the number of daily suctions, particularly the deep ones, and may improve the perception of mucus encumbrance, without side effects.
Exhibitor Data Sheet